Yingcan Xu

ORCID: 0009-0009-9394-963X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiation Therapy and Dosimetry
  • Dermatologic Treatments and Research
  • Cancer, Hypoxia, and Metabolism
  • Erythrocyte Function and Pathophysiology
  • Hair Growth and Disorders
  • Facial Rejuvenation and Surgery Techniques
  • Nanopore and Nanochannel Transport Studies
  • Hemoglobin structure and function
  • Nanoparticle-Based Drug Delivery

Chinese Academy of Medical Sciences & Peking Union Medical College
2023-2025

Sichuan University
2025

West China Hospital of Sichuan University
2025

Liposome, a widely used drug delivery system (DDS), still shows several disadvantages such as dominant clearance by liver and poor target organ deposition. To overcome the drawbacks of liposomes, we developed novel red blood cell (RBC)-liposome combined DDS to modulate tumor accumulation extend circulation life existing liposomal DDS. Here, RBCs, an ideal natural carrier DDS, were utilized carry liposomes avoid them undergo fast in blood. In this study, could either absorbed onto RBCs'...

10.1093/rb/rbad045 article EN cc-by Regenerative Biomaterials 2023-01-01

Radiotherapy (RT) is a highly valuable method in cancer therapy, but its therapeutic efficacy limited by side effects and tumour radiation resistance. The resistance mainly induced hypoxia the microenvironment (TME). As nano-oxygen carrier, Haemoglobin-based oxygen carriers (HBOCs) administration promising strategy to alleviate which may remodel TME ameliorate enable RT more effective. In this study, we administered fractionated combined with HBOC treat Miapaca-2 cell Hela xenografts on nude...

10.1080/21691401.2023.2276768 article EN cc-by Artificial Cells Nanomedicine and Biotechnology 2023-11-23
Coming Soon ...